Pharmaceutics 2013, 5(2), 294-317; doi:10.3390/pharmaceutics5020294
Review

Delivery of Cancer Therapeutics Using Nanotechnology

1email, 2email, 3email, 2,* email and 1,* email
Received: 24 December 2012; in revised form: 15 April 2013 / Accepted: 3 May 2013 / Published: 15 May 2013
(This article belongs to the Special Issue Drug Delivery Using Nanotechnology)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Nanoparticles have been investigated as drug carriers, because they provide a great opportunity due to their advantageous features: (i) various formulations using organic/inorganic materials, (ii) easy modification of targeting molecules, drugs or other molecules on them, (iii) effective delivery to target sites, resulting in high therapeutic efficacy and (iv) controlling drug release by external/internal stimuli. Because of these features, therapeutic efficacy can be improved and unwanted side effects can be reduced. Theranostic nanoparticles have been developed by incorporating imaging agents in drug carriers as all-in-one system, which makes it possible to diagnose and treat cancer by monitoring drug delivery behavior simultaneously. Recently, stimuli-responsive, activatable nanomaterials are being applied that are capable of producing chemical or physical changes by external stimuli. By using these nanoparticles, multiple tasks can be carried out simultaneously, e.g., early and accurate diagnosis, efficient cataloguing of patient groups of personalized therapy and real-time monitoring of disease progress. In this paper, we describe various types of nanoparticles for drug delivery systems, as well as theranostic systems.
Keywords: nanoparticles; nanotechnology; drug delivery; cancer; theranostic nanoparticles
PDF Full-text Download PDF Full-Text [1014 KB, uploaded 15 May 2013 16:21 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Lim, E.-K.; Jang, E.; Lee, K.; Haam, S.; Huh, Y.-M. Delivery of Cancer Therapeutics Using Nanotechnology. Pharmaceutics 2013, 5, 294-317.

AMA Style

Lim E-K, Jang E, Lee K, Haam S, Huh Y-M. Delivery of Cancer Therapeutics Using Nanotechnology. Pharmaceutics. 2013; 5(2):294-317.

Chicago/Turabian Style

Lim, Eun-Kyung; Jang, Eunji; Lee, Kwangyeol; Haam, Seungjoo; Huh, Yong-Min. 2013. "Delivery of Cancer Therapeutics Using Nanotechnology." Pharmaceutics 5, no. 2: 294-317.

Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert